Skip to main content
NCBI home page
Journal of Clinical Pathology logoLink to Journal of Clinical Pathology
. 1992 Apr;45(4):339–343. doi: 10.1136/jcp.45.4.339

Oncogene expression in primary myelodysplasia: correlation with haematological, karyotypic, and clinical progression.

R M Hutchinson 1, J H Pringle 1, S C Knight 1, I Lauder 1, A Potter 1, C Jagger 1
PMCID: PMC495276  PMID: 1577972

Abstract

AIMS: To see if the relative expressions of proto-oncogenes that are increased in acute myeloid leukaemia are raised in patients with myelodysplastic syndromes (MDS), and to see if they increase with progression to leukaemia. To note if there is a correlation between morphology, karyotype, and these proto-oncogene expressions and if any one proto-oncogene can predict prognosis. METHOD: Bone marrow from 130 patients was analysed at six monthly intervals over two years for relative mRNA expression of seven oncogenes, karyotype, and morphology. The technique used slot blot hybridisation and densitometric analysis. The results were compared with 14 surgical controls and 30 people with vitamin deficiency anaemia. RESULTS: Six of seven oncogenes showed increased expression which progressed with time, but did not correlate with morphological or karyotypic changes. Expression of four of the seven oncogenes was increased in megaloblastic and iron deficiency anaemia. C-mos showed differences among the five morphological subgroups; it correlated with abnormal location (p = 0.025) and seemed to influence prognosis. CONCLUSION: Increased proto-oncogenes reflect the overall marrow perturbation in MDS. C-mos may reflect persistence of monocyte pathway which confirms marrow stability.

Full text

PDF
339

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ahuja H. G., Foti A., Zhou D. J., Cline M. J. Analysis of proto-oncogenes in acute myeloid leukemia: loss of heterozygosity for the Ha-ras gene. Blood. 1990 Feb 15;75(4):819–822. [PubMed] [Google Scholar]
  2. Bains M. A., Hoy T. G., Baines P., Jacobs A. Nuclear c-myc protein, maturation, and cell-cycle status of human haemopoietic cells. Br J Haematol. 1987 Nov;67(3):293–300. doi: 10.1111/j.1365-2141.1987.tb02350.x. [DOI] [PubMed] [Google Scholar]
  3. Bar-Eli M., Ahuja H., Gonzalez-Cadavid N., Foti A., Cline M. J. Analysis of N-RAS exon-1 mutations in myelodysplastic syndromes by polymerase chain reaction and direct sequencing. Blood. 1989 Jan;73(1):281–283. [PubMed] [Google Scholar]
  4. Bennett J. M., Catovsky D., Daniel M. T., Flandrin G., Galton D. A., Gralnick H. R., Sultan C. Proposals for the classification of the myelodysplastic syndromes. Br J Haematol. 1982 Jun;51(2):189–199. [PubMed] [Google Scholar]
  5. Berdichevskii F. B., Chumakov I. M., Kiselev L. L. Rasshifrovka pervichnoi struktury uchastka son3 genoma cheloveka: identifikatsiia novogo belka, imeiushchego neobychnuiu strukturu i gomologiiu s DNK-sviazyvaiushchimi belkami. Mol Biol (Mosk) 1988 May-Jun;22(3):794–801. [PubMed] [Google Scholar]
  6. Brown P. C., Tlsty T. D., Schimke R. T. Enhancement of methotrexate resistance and dihydrofolate reductase gene amplification by treatment of mouse 3T6 cells with hydroxyurea. Mol Cell Biol. 1983 Jun;3(6):1097–1107. doi: 10.1128/mcb.3.6.1097. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Chenevix-Trench G., Southall M., Kidson C. The EcoRI RFLP of c-mos in patients with non-Hodgkin's lymphoma and acute lymphoblastic leukemia, compared to geriatric and non-geriatric controls. Int J Cancer. 1989 Jun 15;43(6):1034–1036. doi: 10.1002/ijc.2910430613. [DOI] [PubMed] [Google Scholar]
  8. Clark R., Peters S., Hoy T., Smith S., Whittaker K., Jacobs A. Prognostic importance of hypodiploid hemopoietic precursors in myelodysplastic syndromes. N Engl J Med. 1986 Jun 5;314(23):1472–1475. doi: 10.1056/NEJM198606053142302. [DOI] [PubMed] [Google Scholar]
  9. Druker B. J., Mamon H. J., Roberts T. M. Oncogenes, growth factors, and signal transduction. N Engl J Med. 1989 Nov 16;321(20):1383–1391. doi: 10.1056/NEJM198911163212007. [DOI] [PubMed] [Google Scholar]
  10. Emilia G., Donelli A., Ferrari S., Torelli U., Selleri L., Zucchini P., Moretti L., Venturelli D., Ceccherelli G., Torelli G. Cellular levels of mRNA from c-myc, c-myb and c-fes onc-genes in normal myeloid and erythroid precursors of human bone marrow: an in situ hybridization study. Br J Haematol. 1986 Feb;62(2):287–292. doi: 10.1111/j.1365-2141.1986.tb02931.x. [DOI] [PubMed] [Google Scholar]
  11. Feinberg A. P., Vogelstein B. "A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity". Addendum. Anal Biochem. 1984 Feb;137(1):266–267. doi: 10.1016/0003-2697(84)90381-6. [DOI] [PubMed] [Google Scholar]
  12. Freeman R. S., Pickham K. M., Kanki J. P., Lee B. A., Pena S. V., Donoghue D. J. Xenopus homolog of the mos protooncogene transforms mammalian fibroblasts and induces maturation of Xenopus oocytes. Proc Natl Acad Sci U S A. 1989 Aug;86(15):5805–5809. doi: 10.1073/pnas.86.15.5805. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Grosso L. E., Pitot H. C. Modulation of c-myc expression in the HL-60 cell line. Biochem Biophys Res Commun. 1984 Mar 15;119(2):473–480. doi: 10.1016/s0006-291x(84)80273-9. [DOI] [PubMed] [Google Scholar]
  14. Izak G. Erythroid cell differentiation and maturation. Prog Hematol. 1977;10:1–41. [PubMed] [Google Scholar]
  15. Jacobs A. Oncogenes in the myelodysplastic syndrome. Blood Rev. 1989 Jun;3(2):105–109. doi: 10.1016/0268-960x(89)90005-2. [DOI] [PubMed] [Google Scholar]
  16. Klempnauer K. H., Gonda T. J., Bishop J. M. Nucleotide sequence of the retroviral leukemia gene v-myb and its cellular progenitor c-myb: the architecture of a transduced oncogene. Cell. 1982 Dec;31(2 Pt 1):453–463. doi: 10.1016/0092-8674(82)90138-6. [DOI] [PubMed] [Google Scholar]
  17. Kurata N., Akiyama H., Taniyama T., Marunouchi T. Dose-dependent regulation of macrophage differentiation by mos mRNA in a human monocytic cell line. EMBO J. 1989 Feb;8(2):457–463. doi: 10.1002/j.1460-2075.1989.tb03398.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Layton D. M., Mufti G. J., Lyons J., Janssen J. W., Bartram C. R. Loss of ras oncogene mutation in a myelodysplastic syndrome after low-dose cytarabine therapy. N Engl J Med. 1988 Jun 2;318(22):1468–1469. doi: 10.1056/NEJM198806023182215. [DOI] [PubMed] [Google Scholar]
  19. Melani C., Haliassos A., Chomel J. C., Miglino M., Ferraris A. M., Gaetani G. F., Kaplan J. C., Kitzis A. Ras activation in myelodysplastic syndromes: clinical and molecular study of the chronic phase of the disease. Br J Haematol. 1990 Apr;74(4):408–413. doi: 10.1111/j.1365-2141.1990.tb06327.x. [DOI] [PubMed] [Google Scholar]
  20. Morris C. M., Bowen J., Fitzgerald P. H. Localization of human c-mos to chromosome band 8q11 in leukemic cells with the t(8;21) (q22;q22). Hum Genet. 1989 Mar;81(4):339–342. doi: 10.1007/BF00283687. [DOI] [PubMed] [Google Scholar]
  21. O'Hara B. M., Blair D. G. A threshold effect in the induction of tumorigenicity of an established human cell line by v-mos. Oncogene. 1988 Sep;3(3):295–299. [PubMed] [Google Scholar]
  22. Oskarsson M., McClements W. L., Blair D. G., Maizel J. V., Vande Woude G. F. Properties of a normal mouse cell DNA sequence (sarc) homologous to the src sequence of Moloney sarcoma virus. Science. 1980 Mar 14;207(4436):1222–1224. doi: 10.1126/science.6243788. [DOI] [PubMed] [Google Scholar]
  23. Pierce J. H., Eva A., Aaronson S. A. Interactions of oncogenes with haematopoietic cells. Clin Haematol. 1986 Aug;15(3):573–596. [PubMed] [Google Scholar]
  24. Preisler H. D., Raza A., Larson R., LeBeau M., Browman G., Goldberg J., Grunwald H., Volger R., Verkh L., Singh P. Protooncogene expression and the clinical characteristics of acute nonlymphocytic leukemia: A Leukemia Intergroup pilot study. Blood. 1989 Jan;73(1):255–262. [PubMed] [Google Scholar]
  25. Reddy E. P., Smith M. J., Srinivasan A. Nucleotide sequence of Abelson murine leukemia virus genome: structural similarity of its transforming gene product to other onc gene products with tyrosine-specific kinase activity. Proc Natl Acad Sci U S A. 1983 Jun;80(12):3623–3627. doi: 10.1073/pnas.80.12.3623. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Temin H. M. Evolution of cancer genes as a mutation-driven process. Cancer Res. 1988 Apr 1;48(7):1697–1701. [PubMed] [Google Scholar]
  27. Testa J. R., Parsa N. Z., Le Beau M. M., Vande Woude G. F. Localization of the proto-oncogene MOS to 8q11-q12 by in situ chromosomal hybridization. Genomics. 1988 Jul;3(1):44–47. doi: 10.1016/0888-7543(88)90157-7. [DOI] [PubMed] [Google Scholar]
  28. Trus M. D., Sodroski J. G., Haseltine W. A. Isolation and characterization of a human locus homologous to the transforming gene (v-fes) of feline sarcoma virus. J Biol Chem. 1982 Mar 25;257(6):2730–2733. [PubMed] [Google Scholar]
  29. Valtieri M., Venturelli D., Caré A., Fossati C., Pelosi E., Labbaye C., Mattia G., Gewirtz A. M., Calabretta B., Peschle C. Antisense myb inhibition of purified erythroid progenitors in development and differentiation is linked to cycling activity and expression of DNA polymerase alpha. Blood. 1991 Mar 15;77(6):1181–1190. [PubMed] [Google Scholar]
  30. Xu Y. H., Ishii S., Clark A. J., Sullivan M., Wilson R. K., Ma D. P., Roe B. A., Merlino G. T., Pastan I. Human epidermal growth factor receptor cDNA is homologous to a variety of RNAs overproduced in A431 carcinoma cells. 1984 Jun 28-Jul 4Nature. 309(5971):806–810. doi: 10.1038/309806a0. [DOI] [PubMed] [Google Scholar]
  31. Yunis J. J., Brunning R. D. Prognostic significance of chromosomal abnormalities in acute leukaemias and myelodysplastic syndromes. Clin Haematol. 1986 Aug;15(3):597–620. [PubMed] [Google Scholar]
  32. de Taisne C., Gegonne A., Stehelin D., Bernheim A., Berger R. Chromosomal localization of the human proto-oncogene c-ets. Nature. 1984 Aug 16;310(5978):581–583. doi: 10.1038/310581a0. [DOI] [PubMed] [Google Scholar]
  33. de Taisne C., Gegonne A., Stehelin D., Bernheim A., Berger R. Chromosomal localization of the human proto-oncogene c-ets. Nature. 1984 Aug 16;310(5978):581–583. doi: 10.1038/310581a0. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Pathology are provided here courtesy of BMJ Publishing Group

RESOURCES